ZIM Laboratories

ZIM Laboratories EV/FCF

The EV/FCF (Enterprise Value to Free Cash Flow) of ZIM Laboratories (ZIMLAB.NS) as of Oct 29, 2026 is -60.01. In the previous year, EV/FCF (Enterprise Value to Free Cash Flow) was 1,321.36 — a change of -104.54% (lower).

EV/FCF

-60.01

YoY

-104.54%

Last updated:

EV/FCF (Enterprise Value to Free Cash Flow) of ZIM Laboratories is 2026 -60.01 . EV/FCF (Enterprise Value to Free Cash Flow) of ZIM Laboratories was 2025 1,321.36 . It decreases by -104.54% lower compared to the previous year.

The ZIM Laboratories EV/FCF history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EV/FCF
Date
EV/FCF
Jan 1, 2019
29.84 INR
Jan 1, 2020
131.75 INR
Jan 1, 2021
17.21 INR
Jan 1, 2022
11.94 INR
Jan 1, 2023
483.05 INR
Jan 1, 2024
-7.94 INR
Jan 1, 2025
1,321.36 INR
Jan 1, 2026
-60.01 INR
The ZIM Laboratories EV/FCF history
YEAREV/FCFYoY
-60.01-104.54%
1,321.36-16,737.35%
-7.94-101.64%
483.05+3,945.71%
11.94-30.63%
17.21-86.94%
131.75+341.50%
29.84-44.52%
53.79+186.18%
18.80-63.39%
51.34-207.07%
-47.95+141.96%
-19.82—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

ZIM Laboratories Stock analysis

What does ZIM Laboratories do? Zim Laboratories Ltd. develops, manufactures, and supplies oral solid differentiated generic pharmaceutical formulations and pre-formulation intermediaries (PFI) across therapeutic segments including central nervous system, anti-biotic and anti-infective, gastrointestinal, cardiovascular, analgesic/pain management, urology, and vitamins, minerals, and dietary supplements. The company's technological capabilities focus on drug release modification, solubility and stability enhancement, taste masking, and dosage form transformation. Its product offerings include finished formulations such as tablets, capsules, oral thin films, granules, pellets, taste-masked powders, and dry suspensions, alongside pre-formulation intermediates. The firm generates revenue through the supply of these pharmaceutical products to healthcare providers and distributors within the Indian market. The company's delivery solutions encompass product conceptualization, development, registration filing, manufacturing, and supply, targeting various therapeutic segments. Its differentiated generic formulations cater to specific medical needs, with a focus on innovation in drug delivery systems. Zim Laboratories Ltd. serves the Indian pharmaceutical market, supplying both finished products and pre-formulation intermediates to meet the demands of healthcare institutions and retail pharmacies. Zim Laboratories Ltd. operates as a pharmaceutical company based in Nagpur, Maharashtra, with 525 full-time employees. It develops and manufactures generic pharmaceutical products including oral solid dosage forms and pre-formulation intermediates. The company's revenue streams come from the sale of these products to customers in the healthcare sector, particularly within the Indian market, leveraging its technological capabilities in drug formulation and delivery. ZIM Laboratories is one of the most popular companies on Eulerpool.

Frequently Asked Questions about ZIM Laboratories stock

EV/FCF (Enterprise Value to Free Cash Flow) of ZIM Laboratories is -60.01 in 2026.

EV/FCF (Enterprise Value to Free Cash Flow) of ZIM Laboratories changed from 1,321.36 to -60.01, representing a -104.54% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of EV/FCF (Enterprise Value to Free Cash Flow) ZIM Laboratories since 2006 – with annual values, charts, and detailed analysis.

The EV/FCF ratio measures the enterprise value relative to free cash flow. It captures the true cash-generating ability of a business.

To evaluate EV/FCF (Enterprise Value to Free Cash Flow)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for EV/FCF (Enterprise Value to Free Cash Flow).

A 'good' varies by industry and company stage. On Eulerpool, you can compare EV/FCF (Enterprise Value to Free Cash Flow)'s ZIM Laboratories with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Valuation — ZIM Laboratories

All Key Metrics — ZIM Laboratories